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Foxc2 overexpression enhances benefit of
endothelial progenitor cells for inhibiting neointimal
formation by promoting CXCR4-dependent
homing
Dujuan Li, PhD, Dan Yan, PhD, Weishuo Liu, PhD, Mincai Li, PhD, Jun Yu, PhD, Yan Li, PhD,
Zhiling Qu, MM, and Qiurong Ruan, PhD, Wuhan, China
Objective: Endothelial progenitor cells (EPCs) are capable of enhancing re-endothelialization and attenuating neointimal
formation. However, inefficient homing limits the therapeutic efficacy of EPCs transplantation. CXCR4 plays a critical
role in regulating EPCs homing. Here, we studied the effect of Foxc2 overexpression on CXCR4 expression and the
homing capacity of EPCs as well as the EPCs-mediated therapeutic benefit after artery injury.
Methods: Bone marrow-derived EPCs were transfected with Foxc2 expression vector (Foxc2-EPCs) or empty control
vector (Ctrl-EPCs) and examined 48 hours later. CXCR4 expression of EPCs was detected by flow cytometry and
quantitative reverse transcriptase-polymerase chain reaction. The migration of EPCs toward SDF-1 was evaluated in a
transwell migration assay, and the adhesion to fibronectin was determined using a static adhesion assay. For in vivo
studies, EPCs were injected intravenously into the mice subjected to carotid injury. At 3 days after green fluorescent
protein (GFP)/EPCs delivery, the recruited cells to the injury sites were detected by fluorescent microscopy. Re-
endothelialization and neointimal formation were, respectively, assessed by Evans blue dye at 7 days and by the
morphometric analysis for neointima and media area ratio (N/M) at 28 days after EPCs transfusion.
Results: Foxc2 overexpression significantly increased the surface expression of CXCR4 on EPCs (about 1.9-fold of
Ctrl-EPCs, P < .05). Foxc2-EPCs showed an increased migration toward SDF-1 (P < .05); Foxc2 overexpression
increased also the adhesion capacity of EPCs (P< .05). In vivo, the number of recruited GFP cells was significantly higher
in the mice transfused with Foxc2-GFP/EPCs compared with Ctrl-GFP/EPCs (about 2-fold of Ctrl-GFP/EPCs). The
degree of re-endothelialization was higher in mice transfused with Foxc2-EPCs compared with Ctrl-EPCs (90.3% 1.6%
vs 57.2% 1.3%; P< .05). Foxc2-EPCs delivery resulted in a greater inhibition of neointimal hyperplasia than Ctrl-EPCs
administration (N/M: 0.38 0.03 vs 0.67 0.05, P< .05). Preincubation with CXCR4-Ab, AMD3100, or LY294002
significantly attenuated the enhanced in vitro and in vivo effects of Foxc2-EPCs.
Conclusions: Our findings indicate that Foxc2 overexpression increases CXCR4 expression of EPCs and efficiently enhances
the homing potential of EPCs, thereby improving EPCs-mediated therapeutic benefit after endothelial injury. Foxc2 may be
a novel molecular target for improving the therapeutic efficacy of EPCs transplantation. (J Vasc Surg 2011;53:1668-78.)
Clinical Relevance: Although endothelial progenitor cells (EPCs) are capable of reducing the postintervention complications
and increasing ischemic neovascularization, the extent of EPCs homing was shown to be rather low in most clinical settings,
greatly limiting the effectiveness of EPCs therapy. In the present study, we report that Foxc2 overexpression enhances the
homing capacity of EPCs and thereby improves the EPCs-mediated therapeutic benefit after artery injury. Our results suggest
that Foxc2 may hopefully become a novel therapeutic molecular target for improving therapeutic effectiveness of EPCs
delivery. On the other hand, some risk factors for coronary artery disease impair CXCR4 signaling. For instance, EPCs from
diabetes mellitus or coronary artery disease patients exhibited reduced CXCR4 expression and diminished the therapeutic
potential of autologous transplantation. Up-regulation of CXCR4 signaling by Foxc2 overexpression might compensate for
the reduced effects, and thereby improve the therapeutic efficacy of autologous EPCs transplantation.
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1668Endothelial disruption or dysfunction is vital to the
nitiation and progression of numerous vascular diseases.
hus, maintenance of endothelial integrity and promotion
f early re-endothelialization are of paramount importance
or reducing cardiovascular diseases and the postinterven-
ion complications. Accumulating evidence suggests that
ndothelial progenitor cells (EPCs) mobilized or trans-
used are capable of facilitating endothelial repair through
irect differentiation into endothelial cells1,2 and/or via
he paracrine mechanisms.3,4 The vasoregenerative effects
f EPCs depend on their homing to the vascular injury
ites. Indeed, the number of recruited EPCs appears to be
elated to not only their circulating numbers but the func-
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Volume 53, Number 6 Li et al 1669tional properties of EPCs homing. Studies show that
CXCR4 is a key molecule in regulating EPCs homing and
recruitment.5-8 Emerging evidence exists for the impaired
CXCR4-dependent homing and the low engraftment of
EPCs due to some risk factors for coronary artery disease.9,10
These underline the need for new strategies capable of increas-
ing the CXCR4-mediated homing potential of EPCs.
The Foxc2 protein, a member of the Forkhead/Fox
transcription factor family, is essential for the cardiovascular
system. Foxc2 plays an important role in the combinatorial
regulation of endothelial gene expression during embry-
onic development.11 Foxc2 is recognized as a novel regu-
lator of angiogenesis via induction of integrin 312 and
angiopoietin-2 expression.13 Foxc2 might be involved in
the angiogenesis under pathologic conditions, just as re-
cent studies revealed that Foxc2 expression is associated
with the human heart failure14 and increased in periin-
farcted zones of the rat left ventricle.15 Notably, Foxc2
directly induces the expression of CXCR4 in endothelial
cells.16 Recently, it is accepted that the phenotypic and
functional behavior of endothelial colony forming cells
(ECFCs, also called “late” EPCs) is very similar to mature
endothelial cells.17 Until now, there are no data showing
the effect of Foxc2 on the functional properties of EPCs.
Based on the effect of Foxc2 on the properties of endothe-
lial cells, we sought to determine whether Foxc2 may affect
CXCR4 expression and the homing capacity of EPCs as
well as the EPCs-mediated endothelial repair.
METHODS
Animals. Male wild type C57BL/6J mice (25-35g)
were obtained from the experimental animal center of
TongjiMedical College,HuazhongUniversity of Science and
Technology,Wuhan,China.Greenfluorescent protein (GFP)
transgenicC57BL/6Jmice (25-35g)were from JacksonLab-
oratory (Bar Harbor, Me). All experiments were performed
in accordance with the Guide for the Care and Use of
Laboratory Animals. All procedures were approved by the
Animal Use Subcommittee at the Huazhong University of
Science and Technology, P. R. China.
Preparation of bone marrow-derived EPCs. Bone
marrow-derived EPCs were isolated and cultured as previ-
ously described in detail.18 Briefly, bone marrow was aspi-
rated from femurs and tibias of mice. Isolated mononuclear
cells were cultured on a fibronectin-coated dish in endothe-
lial cell basal medium-2 (EBM-2) supplemented with en-
dothelial growth medium-SingleQuots (Clonetics, San
Diego, Calif). After 24 hours, nonadherent cells were re-
moved. Adherent cells were cultured for further 15 to 21
days with medium refreshment every second day, which
gave EPCs.
Flow cytometry analysis. Adherent cells were trypsi-
nized and incubated with phycocerythrin (PE)-conjugated
anti-CD34, PE-conjugated anti-CD45 (Biolegend, San
Diego, Calif), and PE-conjugated anti-CXCR4 (BD Bio-
sciences Pharmingen, San Diego, Calif) for 45 min at 4°C.
Flow cytometry was performed using FACS-Calibur cy-
tometer (Becton-Dickinson, Franklin Lakes, NJ). zImmunofluorescence analysis. Cells were fixed with
% paraformaldehyde (PFA), permeabilized with 0.1% Tri-
on X-100, and blocked with 0.5% bovine serum albumin
BSA). Slides were incubated with rabbit anti-vWF, CD31,
E-cadherin, and CXCR4 Abs (all from Santa Cruz Bio-
echnology, Santa Cruz, Calif), then with Rhodamine-
abeled goat anti-rabbit secondary Abs (Molecular Probes;
nvitrogen, Carlsbad, Calif). The slides were counter-
tained for 5 minutes with Hoechst 33342 (Sigma-Aldrich,
t. Louis, Mo). A fluorescence microscopy was used to
nalyze the antibody binding.
Uptake of DiI-acLDL. Cells were incubated with
,1=-dioctadecyl-3,3,3=,3=-tetramethylindocarbocyanine-
abeled acetylated low density lipoprotein (DiI-acLDL;
.02 mg/mL; Invitrogen) at 37°C for 2 hours. After fixed,
he cells were incubated with Hoechst 33342. Dual posi-
ive cells were observed with a fluorescent microscope.
Matrigel tube formation assay. Ninety-six well plates
ere coated with 40 L of matrigel (BD Biosciences,
ranklin Lakes, NJ). After 45 minutes of polymerization at
7°C, cells were plated at 1 104 cells/well and incubated
or 24 hours at 37°C. Tube-like structures were observed
nder an inverted phase-contrast microscope.
Plasmid transfection. Mouse Foxc2 expression vec-
or was as described,19 kindly provided by Dr Omoteyama
of Nihon University School of Dentistry. EPCs were
ransiently transfected by using FuGENE HD transfection
eagent (Roche, Penzberg, Germany) with pooled Foxc2
xpression vector (Foxc2-EPCs) or with empty control
ector (Ctrl-EPCs), following the reagent manufacturer’s
rotocol. Briefly, the plasmid DNA solution was mixed
ith the transfection reagent in a DNA: transfection re-
gent ratio of 2:5 (g/L) for 15 minutes and then added
o the culture medium. Forty-eight hours after transfec-
ion, the cells were used in the different assays.
Adhesion assays. EPCs were stimulated with or with-
ut 100 ng/mL SDF-1 (Peprotech, Rocky Hill, NJ) for
0minutes before the assays. 1 105 EPCs were seeded on
ach well of a 24-well plate, precoated with fibronectin.
fter 30 minutes of incubation at 37°C, plates were vigor-
usly washed to remove nonadherent cells. After being
xed with 2% PFA, adherent cells were stained with
oechst 33342. The number of adherent cells was quanti-
ed with a fluorescent microscope in five randomly selected
icroscope fields (200) per well.
Migration assay. EPCs (2  104 in 100 L) were
dded to the upper compartment of the transwell system
Corning, Corning, NY). Six hundredmicroliters of serum-
ree basal medium containing phosphate-buffered saline
PBS), or 100 ng/mL SDF-1 was added to the lower
ompartment. After 18 hours at 37°C, the filter was fixed
ith 2% PFA and the upper side carefully cleaned with a
otton swab. For quantification, the cells on the lower side
ere stained with 0.1% crystal violet and counted in six
andomly chosen fields (200) under a microscope.
Quantitative reverse transcriptase-polymerase chain
eaction (qRT-PCR). Total RNAwas extracted with TRI-
ol reagent (Invitrogen) and reversely transcribed using
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June 20111670 Li et alReverTra Ace Kit (Toyobo, Osaka, Japan), and qRT-PCR
was performed on an Mx3000P real-time PCR system
using SYBR Green Real-time PCR Master Mix (Toyobo).
Primer pairs for Foxc2,19 CXCR4,20 and glyceraldehyde-
3-phosphate dehydrogenase19 were used.
Western blot analysis. EPCs protein was harvested by
cell lysis buffer, separated by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis and transferred to nitrocel-
lulose membranes. The following antibodies were used:
rabbit anti-CXCR4, CD31, VE-cad, FLK-1, -actin,
phospho-Akt, and Akt Abs (all from Santa Cruz Biotech-
nology), and rabbit anti-Foxc2 Ab (Abcam, Cambridge,
United Kingdom). Proteins were visualized with horserad-
ish peroxidise-conjugated anti-rabbit IgG (Cell Signaling
Technology, Boston, Mass), followed by use of the en-
hanced chemiluminescent reagents (Thermo, Fisher, Rock-
ford, Ill). To detect SDF-1 stimulated phosphorylation of
Akt, EPCs were preincubated with 100 ng/mL SDF-1 for
10 minutes before harvesting protein.
Mouse carotid injury and EPCs transfusion. For all
surgical procedures, mice were anesthetized by intraperito-
neal injection of 50 mg/kg sodium pentobarbital (Sigma).
Carotid injury was established as described previously.21
Briefly, a 0.014-inch-percutaneous transluminal coronary
angioplasty flexible guidewire was introduced into the left
common carotid via the external carotid artery and with-
drawn/reinserted three times. Themice received 100L of
PBS, 5  105 Ctrl-EPCs, or 5  105 Foxc2-EPCs by tail
vein injection within 10 minutes following induction of
vascular injury. In some experiments, EPCs were incubated
with CXCR4 monoclonal blocking Ab (10 g/mL; BD
Biosciences Pharmingen), isotype control (Chemicon/Milli-
pore, Billerica,Mass), or AMD3100 (10M; SigmaAldrich),
or LY294002 (10 M; Cell Signaling Technology, Danvers,
Mass) for 30 minutes at 37°C prior to the injection.
Histologic assessment. For assessment of re-
endothelialization, animals were perfused with Evans blue
dye (Sigma) at 7 days after EPCs delivery, as described
previously.21 Planimetric analysis was performed to calcu-
late the ratio of re-endothelialized area, defined as an area
not stained with Evans blue for the entire luminal surface
area of the injured artery. For morphometric analysis of
neointima formation, at 28 days following surgery, the
injured carotid arteries were fixed, embedded in paraffin,
serially cut into 5-m sections, and every 20th section
stained with hematoxylin and eosin. The neointima and
media cross-sectional area ratio (N/M) was measured on
30 to 35 sections per animal using the image analysis
software. To examine the homing capacity, at 3 days after
delivery of EPCs from GFP/mice, a subset of perfusion-
fixed carotid arteries were opened longitudinally and di-
rectly assessed for the number of GFP cells by en face
fluorescence microscopy. The cryosections of the other
carotid arteries were prepared and observed for the number
of adherent GFP cells by the cross-section fluorescence
microscopy.
Statistical analysis. All data are expressed as mean 
SEM. For analysis of differences between two groups, a ctudent’s t test was performed. Differences between mul-
iple groups were analyzed by one-way analysis of variance
ith a post hoc least significant difference analysis. A value
f P .05 was considered statistically significant. Statistical
nalysis was conducted using SPSS 13.0 software (SPSS,
hicago, Ill).
ESULTS
Characterization of endothelial progenitor cells.
one marrow derived–mononuclear cells were isolated and
ultured for 15 to 21 days, which exhibited a cobblestone-
ike morphology (Fig 1, A and B). Immunofluorescence
emonstrated that the majority of adherent cells expressed
he endothelial cell markers, including CD31 (Fig 1, C),
E-cad (Fig 1, D), and vWF (Fig 1, E). Flow cytometric
nalysis revealed that only very few cells expressed the
ematopoietic marker CD34 (Fig 1, G) or leukocytic
arker CD45 (Fig 1, H). Western blot analysis further
onfirmed the expression of endothelial cell markers, in-
luding CD31, VE-cad, and FLK-1 (Fig 1, I). Moreover,
he majority of adherent cells (95%) were found positive
or uptake of DiI-acLDL (Fig 1, J). In addition, these cells
ere capable of assembling into tube-like structures when
lated in matrigel (Fig 1, K). On the basis of these mor-
hologic and functional characteristics, the cells in our
tudy were confirmed EPCs characterized as ECFCs.17,22
Confirmation of Foxc2 overexpression in EPCs. At
8 hours posttransfection, the transcription and expression
f Foxc2 in EPCs were confirmed by qRT-PCR and West-
rn blot. Neither the transfection reagent nor the empty
ontrol vector affected Foxc2 expression in EPCs, whereas
he transfection with Foxc2 expression vector efficiently
nduced the upregulation of Foxc2 mRNA (about 4.5-fold
f control value [P  .05]; Fig 2, A). Furthermore, West-
rn blot showed that Foxc2 protein levels in Foxc2-EPCs
ere increased to 3.5 folds of the other 3 groups (P .05;
ig 2, B).
Foxc2 overexpression upregulates CXCR4 expres-
ion of EPCs. To explore whether Foxc2 overexpression
ay affect CXCR4 expression of EPCs, we first evaluated the
urface expression of CXCR4 on EPCs using flow cytometry.
s shown in Fig 2, C, Foxc2 overexpression significantly
ncreased surface expression of CXCR4 on EPCs (P  .05).
luorescence microscopy and Western blot analysis further
onfirmed that Foxc2 overexpression upregulated CXCR4
xpression of EPCs (Fig 2, D and E). qRT-PCR analysis
howedCXCR4mRNAexpression in Foxc2-EPCswas about
wo-fold of Ctrl-EPCs or EPCs (Fig 2, F), suggesting that
pregulation of CXCR4 expression appeared to be related to
n increase in CXCR4 mRNA levels.
Foxc2 overexpression increases the SDF-1–induced
igration and adhesion of EPCs in vitro. To determine
hether the induction of CXCR4 expression by Foxc2 over-
xpression is functionally involved in the migration and adhe-
ion capacities of EPCs, we investigated their migration to-
ard SDF-1 in a transwell migration assay, and their
dhesion to fibronectin using an adhesion assay under static
onditions. The number of spontaneous migration was not
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Volume 53, Number 6 Li et al 1671significantly different among EPCs, Ctrl-EPCs, and Foxc2-
EPCs (Fig 3, A). Foxc2-EPCs demonstrated an increased
response to SDF-1–mediated chemotaxis (about 1.4-fold of
Ctrl-EPCs or EPCs; P  .05; Fig 3, A). The basal adhesion
capacity had no obvious difference among the three groups
(Fig 3, B). After stimulation with SDF-1, although the
adhesion capacity of EPCs or Ctrl-EPCs was increased,
Foxc2-EPCs had a further enhance (P .05; Fig 3, B).
It has been documented that after exposure to
SDF-1 at high concentrations (1g/mL and above)
induces the desensitization of the cells to further SDF-1
stimulation, via the endocytosis of the cell surface
Fig 1. Morphologic and functional analysis of bone
marrow-derived mononuclear cells were cultured for 15 t
cobblestone pattern were found after 15 days. B, The sim
endothelial cells (HUVECs). C-F, Immunofluorescence
endothelial markers of CD31 (C), VE-cadherin (D), vW
stained with Hoechst 33342. G-H, Flow cytometry reve
(CD45; H) was expressed on the minority of the cells
histograms the respective isotype controls. I,Western-blo
HUVECs were used as positive controls; -actin protein
evaluated by DiI-ac-LDL incorporation (J) and by the fo
bars, 100 m A-F and J; 200 m (K).CXCR4 molecule.23 We therefore examined the effects wf high SDF-1 concentrations on Foxc2-EPCs. To this
nd, Foxc2-EPCs were incubated overnight with
g/mL SDF-1, and evaluated for the CXCR4 cell
urface expression. Unexpectedly, there was only a 43%
ecrease in cell surface receptor expression in Foxc2-
PCs, whereas in Ctrl-EPCs this decrease reached up to
7% (P  .05; Fig 3, C). Desensitized cells were also
ssayed for the SDF-1 (100 ng/mL)-directed che-
otaxis and adhesion. Ctrl-EPCs decreased by nearly
0% in the SDF-1-mediated migration and adhesion,
hereas these responses of Foxc2-EPCs were hardly
ffected (Fig 3, D and E), indicating that Foxc2-EPCs
w-derived endothelial progenitor cells (EPCs). Bone
days. A, The confluent endothelial-like monolayers with
orphology was observed in human umbilical cord vein
onstrated that the majority of the cells expressed the
) compared to isotype-NC (F). Nuclei were counter-
hat the hematopoietic (CD34; G) or leukocytic marker
k histograms represent specific fluorescence, and silver
ysis confirmed the expression of endothelial cell markers;
ession was used as internal standard. Culture cells were
on of vascular tube-like structures on matrigel (K). Scalemarro
o 21
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F (E
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rmatiere less responsive to SDF-1–induced desensitization.
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June 20111672 Li et alUpregulation of CXCR4/PI3K/Akt signaling was
involved in the effects of Foxc2 overexpression on
EPCs migration and adhesion. Based on the evidence
that PI3K/Akt is a known downstream target of CXCR4
receptor,24 we determined whether Foxc2 overexpression
affects the activity of PI3K/Akt signaling. Western blot anal-
ysis revealed that the basal Akt-phosphorylation was not sig-
nificantly different between Ctrl-EPCs and Foxc2-EPCs,
whereas SDF-1–stimulated increase of Akt-phosphorylation
in Foxc2-EPCs exceeded that in Ctrl-EPCs (Fig 3, F). Fur-
thermore, the increased Akt-phosphorylation in Foxc2-EPCs
Fig 2. A-B, Liposome-mediated transfection of Foxc2 e
progenitor cells (EPCs). At 48 hours posttransfection, th
reverse transcriptase-polymerase chain reaction (qRT-PC
measured by Western blot (B; n 5 per group). GAPDH
standard. Results for EPCs transfected with HD alone (E
expression vector (Foxc2-EPCs) were normalized to the u
or Ctrl-EPCs. C-F, Foxc2 overexpression induced CXCR
surface expression. Representative histograms for isotyp
EPCs (black) were shown (n  5 independent experime
CXCR4 expression in Foxc2-EPCs (middle) compared w
bars, 100 m. Western-blot E, and qRT-PCR (F) showi
(n  5 per group). GAPDH mRNA and -actin prot
Ctrl-EPCs or EPCs.was inhibited by preincubation with CXCR4-Ab, CXCR4 tntagonist AMD3100, or PI3K inhibitors LY294002 (Fig 3,
). Next, we tested the ability of CXCR4-Ab, AMD3100,
r LY294002 to impair the migration and adhesion
unction of Foxc2-EPCs. As observed in the above re-
ults, Foxc2 overexpression increased the migration and
dhesion capacities of EPCs. However, the increased
ffects were reduced by pretreatment of Foxc2-EPCs
ith the CXCR4-Ab, AMD3100, or LY294002 (Fig 3,
and H).
Foxc2 overexpression contributes to EPCs homing
nd recruitment into the sites of vascular injury. To test
sion vector upregulated Foxc2 expression of endothelial
ression of Foxc2 mRNA was determined by quantitative
A) (n  5 per group), and the protein expression was
NA and -actin protein expression were used as internal
HD), the empty control vector (Ctrl-EPCs), or Foxc2
sfected EPCs (EPCs). *P  .05 vs EPCs, EPCs 	HD,
ression of EPCs.C, Flow cytometry analysis of CXCR4
control EPCs (silver), Ctrl-EPCs (gray), and Foxc2-
D, Immunofluorescence confirmed the upregulation of
trl-EPCs (left). The isotype NC was also shown. Scale
CR4 expression of EPCs, Ctrl-EPCs, and Foxc2-EPCs
pression were used as internal standard. *P  .05 vsxpres
e exp
R) (
mR
PCs	
ntran
4 exp
e IgG
nts).
ith C
ng CX
ein exhe hypothesis that the enhanced in vitro capacities of EPCs
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Volume 53, Number 6 Li et al 1673achieved by Foxc2 overexpression would translate into the
improved in vivo homing function, the mice subjected to
carotid injury were intravenously injected with PBS, Foxc2-
GFP/EPCs, or Ctrl-GFP/EPCs. Three days later, cross-
section or en face fluorescent microscopy showed the de-
livered GFP cells were recruited at injury sites. The number
of recruited GFP cells was significantly higher in the mice
transfused with Foxc2-GFP/EPCs compared with Ctrl-
GFP/EPCs (about two-fold of Ctrl-GFP/EPCs; Fig 4,
A and B). Homing of transfused cells was strictly re-
stricted to the injury sites, with no detectable cells in
uninjured parts or in the contralateral vessel. Impor-
tantly, the Foxc2-overexpressing-induced effect was sig-
nificantly reduced by pretreatment of Foxc2-EPCs with
CXCR4-Ab, AMD3100, or LY294002 for 30 minutes
Fig 3. A-B, Effects of Foxc2 overexpression on S
progenitor cells (EPCs) in vitro. A, Migration assay:
migrate to the lower compartment of transwell migrat
The migrated cells were stained and counted under a m
	 SDF-1 or Ctrl-EPIC	 SDF-1. B, Adhesion assay: T
allowed to adhere to fibronectin for 30 minutes. Adh
microscope. n 5 independent experiments. *P .05 vs
Foxc2-EPCs to SDF-1–induced desensitization. Foxc2-
(1g/mL), and evaluated for the surface CXCR4 expre
induced migration (D) and adhesion (E). Results for the
5 independent experiments. *P  .05 compared with t
PI3K/Akt signaling was involved in the enhanced in
overexpression. F, Representative Akt phosphorylation o
by Western blot (n  5 per group); quantification w
Ctrl-EPCs without SDF-1 stimulation. Quantification a
of EPCs after treatment with AMD3100, CXCR4-Ab,
SDF-1; #P  .05 vs Foxc2-EPCs 	 SDF-1.prior to their injection (Fig 4, A and B). sFoxc2 overexpression enhances the therapeutic
enefit of EPCs after artery injury. To assess the effect of
oxc2-EPCs delivery on endothelial repair, re-endothelial-
zation was examined using Evens blue staining of the
njury vessels. At 7 days after EPCs delivery, the degree of
e-endothelialization was significantly higher in mice trans-
used with Ctrl-EPCs compared with PBS (P  .05; Fig 5,
and B). Nevertheless, Foxc2-EPCs delivery further in-
reased the degree of re-endothelialization relative to Ctrl-
PCs (90.3%  1.6% vs 57.2%  1.3%, P  .05; Fig 5, A
nd B). Further experiments indicated that more GFP cells
ere incorporated into the CD31 positive endothelial layer
t 14 days after Foxc2-GFP/EPCs compared with Ctrl-
PCs delivery (46.67%  7.09% vs 31.50%  5.26%, P 
05; Fig 5,C). Next, to evaluate whether Foxc2 overexpres-
-induced migration and adhesion of endothelial
8 hours after transfection, the cells were allowed to
ystem, containing 100 ng/mL SDF-1 for 18 hours.
ope. n 5 independent experiments. *P .05 vs EPC
lls pretreated with or without SDF-1 stimulation were
cells were stained and observed under a fluorescent
	 SDF-1 or Ctrl-EPIC	 SDF-1.C-E, Response of
s and Ctrl-EPCs were incubated overnight with SDF-1
by flow cytometry (C) and the SDF-1 (100ng/mL)-
sitized cells were normalized to the untreated cells. n
treated control cells. F-H, Upregulation of CXCR4/
migration and adhesion function of EPCs by Foxc2
s with or without stimulation by SDF-1 was measured
ressed as p-Akt/Akt ratio. Data were normalized to
is for SDF-1 induced migration (G) and adhesion (H)
294002 (n  5 per group). *P  .05 vs Ctrl-EPCs 	DF-1
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June 20111674 Li et alhyperplasia, the carotid arteries were harvested 28 days after
EPCs delivery. Wire-induced injury resulted in the promi-
nent neointimal formation in the arteries from PBS-in-
jectedmice (N/M: 1.94 0.06; Fig 6). Ctrl-EPCs delivery
led to a 65% reduction in N/M compared with PBS control
(P  .05). However, the inhibitory effect of Foxc2-EPCs
delivery was greater than Ctrl-EPCs (0.38  0.03 vs 0.67
 0.05, P  .05; Fig 6). Finally, preincubation with
CXCR4-Ab, AMD3100, or LY294002 significantly atten-
Fig 4. Effect of Foxc2 overexpression on homing and re
of vascular injury and its correlation with CXCR4/PI3
transfused with phosphate-buffered saline (PBS), Ctrl-gr
with or without pretreatment with AMD3100, CXCR4-
cells to the injury sites was detected by cross-section or
crographs of the cross-section fluorescent microscopy fo
carotid arteries (sham). Scale bars, 200 m. And the
circumference). n  3 to 5 per group. *P  .05. B, Rep
under an en face fluorescent microscopy. Scale bars, 100
n  5 per group. *P  .05.uated the enhanced therapeutic potential of Foxc2-EPCs ior promoting re-endothelialization and inhibiting neoin-
imal formation (Figs 5, A and B, and 6).
ISCUSSION
It is accepted that EPCs are capable of enhancing
e-endothelialization and diminishing neointimal forma-
ion. In the context of the regenerative arterial remodeling,
n adequate homing of EPCs plays an important role.
owever, the extent of homing was shown to be rather low
ent of endothelial progenitor cells (EPCs) into the sites
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far. In the present study, Foxc2 overexpression efficiently
increased EPCs homing to the sites of vascular injury,
thereby resulting in enhanced re-endothelialization and
attenuated neointimal formation. In vitro, Foxc2 overex-
pression markedly upregulated CXCR4 expression in EPCs
and increased the migration and adhesion capacities of
EPCs.Moreover, the enhanced in vitro and in vivo function
by Foxc2 overexpression was associated with the upregula-
tion of CXCR4 and the activation of PI3K/Akt signal
pathway. These findings provide novel insights into the
effects of Foxc2 on vascular homeostasis.
We demonstrated that Foxc2 overexpression markedly
Fig 5. Foxc2 overexpression facilitated endothelial prog
injury. A, Representative photographs of injured carot
re-endothelialized area assessed by the percentage of Eva
group. *P .05. C, Incorporation of EPCs into the rege
protein (GFP)/EPCs or Foxc2-GFP/EPCs delivery, G
identified by immunostaining for CD31 (Rhodamine, re
positive endothelial cells in the cross-section of injured aincreased the expression of CXCR4 in EPCs. Consistent tith our finding, hypoxia,25 ex vivo short-time culture,26
r cytokine expansion culture27,28 may upregulate CXCR4
xpression of the stem cells. However, the upregulation of
XCR4 is due to translocation of intracellular CXCR4 to
he cell surface. Here, we particularly observed that Foxc2
verexpression stimulated CXCR4 gene transcription, sug-
esting that the upregulation of CXCR4 expression by
oxc2 overexpression was at least partially due to the de
ovo synthesis. Integrative genomic analyses of CXCR4
ene indicate that FOX-binding sites of mammalian
XCR4 orthologs is almost completely conserved.29 Fur-
hermore, Foxc2 directly regulates CXCR4 expression in
ndothelial cells by activating its promoter.16 Therefore,
r cells (EPCs)-mediated re-endothelialization after artery
eries stained by Evans blue. B, Quantification of the
e nonstaining area for the entire injured area. n 5 per
ed endothelium. At 14 days after Ctrl-green fluorescent
ells (green) were detected within the endothelial layer
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there was hardly any response to SDF-1–induced desen-
sitization in Foxc2-EPCs. It is well documented that the
cell desensitization results from the internalization of
CXCR4 after exposure to SDF-1.23 Our data showed that
in Foxc2-EPCs, there was only a 43% decrease in cell
surface CXCR4 expression compared with an 87% decrease
in Ctrl-EPCs after exposure to SDF-1. Thus, we guess
that the less desensitization of Foxc2-EPCs may be ex-
plained by constant upregulation of CXCR4 compensating
for internalization of CXCR4 and partially overcoming the
desensitization to SDF-1. The less desensitization might
contribute to the enhanced therapeutic benefit of Foxc2-
EPCs.
CXCR4 is a key molecule in regulating the therapeutic
potential of EPCs. Recently, it has been reported that the
differences in donor CXCR4 expression levels are corre-
lated with the therapeutic outcome of angiogenic treat-
Fig 6. Foxc2 overexpression enhanced the capacity o
formation. The cross-sections of carotid arteries at 28 day
(M) and neointima (N) are labeled for reference. Arr
cross-sections of the carotid arteries from the mice tran
Foxc2-EPCs with or without AMD3100, CXCR4-mAb,
of the cross-section N/M, n  5 per group, *P  .05.ment with EPCs.30 More important, CXCR4 expression letermines the functional activity of bone marrow-derived
ononuclear cells for therapeutic neovascularization in
cute ischemia.31 To explore the therapeutic potential of
PCs that express high levels of CXCR4 by Foxc2 overex-
ression in the cardiovascular diseases of endothelial injury,
e produced a mouse model of carotid injury. Our results
howed that Foxc2 overexpression significantly enhanced
he therapeutic potential of EPCs for promoting re-
ndothelialization and inhibiting neointimal formation,
nd the improved therapeutic benefit was clearly im-
aired by CXCR4-Ab or AMD3100. Consistent with our
esults, Chen et al reported that the direct upregulation
f CXCR4 expression in human EPCs by gene transfer
esults in an improvement of re-endothelialization ca-
acity.32
Homing is a prerequisite for the transfused cells via the
ascular route to exhibit their activity in the target tissue. It
s now evident that SDF-1 expression is markedly upregu-
othelial progenitor cells (EPCs) to inhibit neointimal
tinjury were stained with hematoxylin and eosin. Media
ndicate the internal elastic lamina. A, Representative
with phosphate-buffered saline (PBS), Ctrl-EPCs, or
294002. Scale bars, 200 m. B,Morphometric analysisf end
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in homing of EPCs to the sites of denudation.35 Concern-
ing how Foxc2 overexpression modulates the therapeutic
potential of EPCs, we hypothesized that the enhanced
therapeutic potential of Foxc2-EPCs might be exerted via
the increased CXCR4-dependent homing. Indeed, Foxc2
overexpression enhanced the SDF-1-induced migration
and adhesion in vitro. In vivo, Foxc2-EPCs exhibited the
increased homing and recruitment into the injury sites.
Moreover, both the enhanced in vitro and in vivo func-
tional properties of Foxc2-EPCs can be attenuated by
CXCR4-Ab or AMD3100, suggesting the enhanced hom-
ing of EPCs by Foxc2 overexpression was CXCR4-
dependent. Further, more GFP cells were observed within
the CD31 positive endothelial layer 14 days after Foxc2-
GFP/EPCs delivery, suggesting that the delivered Foxc2-
EPCs were actually incorporated into the regenerated en-
dothelial layer. Thus, it is likely that Foxc2-EPCs
differentiate into endothelial cells, thereby resulting in the
rapid re-endothelialization after artery injury.
It is well-known that PI3K/Akt is an important down-
stream of SDF-1/CXCR4 signal pathway and plays an
essential role in regulating the migratory and homing po-
tential of progenitor cells.36 In order to understand the
molecular mechanism, we hypothesized that PI3K/Akt
signaling might be related to the enhanced EPCs function
by Foxc2 overexpression mentioned above. Our data
showed that Akt phosphorylation was more responsive to
SDF-1 in Foxc2-EPCs compared with Ctrl-EPCs. More-
over, the enhanced in vitro function as well as the improved
in vivo homing potential and therapeutic benefit of Foxc2-
EPCs could be attenuated by PI3K inhibitors LY294002.
These results suggest that the improved effects by Foxc2
overexpression are mainly dependent on the CXCR4-
mediated PI3K/Akt signal pathway.
There are several limitations in our study. First, impair-
ment of EPCs function by cardiovascular risk factors has to
be taken into account when considering EPC-based ther-
apy. However, we did not investigate the effect of Foxc2
overexpression on dysfunctional EPCs from the high-risk
subjects. Second, it has been reported that Foxc2 is associ-
ated with the metastasis and angiogenesis of tumor.37,38
Thus, the clinical safety of Foxc2-based therapy should still
be verified. Finally, we did not investigate the influence of
Foxc2 inhibition on the migration and homing of EPCs, so
the definite roles of Foxc2 in the homing of EPCs remain to
be clarified.
In conclusion, we demonstrated that Foxc2 overex-
pression enhances EPCs homing potential and therapeutic
benefit of EPCs for facilitating re-endothelialization and
inhibiting neointimal hyperplasia. These findings also raise
the possibility that Foxc2 may potentially become a novel
therapeutic molecular target for improving therapeutic
benefit of EPCs transplantation. Future studies will have to
examine the effect of Foxc2 overexpression on ischemic
neovascularization of EPCs.The authors are grateful to Dr Omoteyama K (Nihon
niversity School of Dentistry) for providing the mouse
oxc2 expression vector.
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